The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Distinct Contributions of Vaccine-Induced Immunoglobulin G1 (IgG1) and IgG2a Antibodies to Protective Immunity against Influenza
Open accessAbstract
Vaccination represents the most effective form of protection against influenza infection. While neutralizing antibodies are typically measured as a correlate of vaccine-induced protective immunity against influenza, nonneutralizing antibodies may contribute to protection or amelioration of disease. The goal of this study was to dissect the individual contributions of the immunoglobulin G1 (IgG1) and IgG2a antibody isotypes to vaccine-induced immunity against influenza virus. To accomplish this, we utilized an influenza vaccine regimen that selectively enhanced IgG1 or IgG2a antibodies by using either DNA or viral replicon particle (VRP) vectors expressing influenza virus hemagglutinin (HA) (HA-DNA or HA-VRP, respectively). After HA-DNA vaccination, neutralizing antibodies were detected by both in vitro (microneutralization) and in vivo (lung viral titer) methods and were associated with increased IgG1 expression by enzyme-linked immunosorbent assay (ELISA). Vaccination with HA-VRP did not strongly stimulate either neutralizing or IgG1 antibodies but did induce IgG2a antibodies. Expression of IgG2a antibodies in this context correlated with clearance of virus and increased protection against lethal influenza challenge. Increased induction of both antibody isotypes as measured by ELISA was a better correlate for vaccine efficacy than neutralization alone. This study details separate but important roles for both IgG1 and IgG2a expression in vaccination against influenza and argues for the development of vaccine regimens that stimulate and measure expression of both antibody isotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12
REED, L. J., & MUENCH, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 19,926
A simple method of estimating 50 per cent end points
Muench, H. (1938) · Medical Entomology and Zoology · Cited by 8,376
Interferon-γ and B Cell Stimulatory Factor-1 Reciprocally Regulate Ig Isotype Production
Snapper, C. M., & Paul, W. E. (1987) · Science · doi:10.1126/science.3107127 · Cited by 1,920
A DNA transfection system for generation of influenza A virus from eight plasmids
Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G., & Webster, R. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100133697 · Cited by 1,565
Avian Influenza A (H5N1) Infection in Humans
(2005) · New England Journal of Medicine · doi:10.1056/nejmra052211 · Cited by 1,285
Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,037
FcR γ chain deletion results in pleiotrophic effector cell defects
Takai, T., Li, M., Sylvestre, D., Clynes, R., & Ravetch, J. V. (1994) · Cell · doi:10.1016/0092-8674(94)90115-5 · Cited by 951
Rowe, T., Abernathy, R. A., Hu-Primmer, J., Thompson, W. W., Lu, X., Lim, W., Fukuda, K., Cox, N. J., & Katz, J. M. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.4.937-943.1999 · Cited by 811
Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine
Treanor, J. J., Campbell, J. D., Zangwill, K. M., Rowe, T., & Wolff, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055778 · Cited by 698
Hepatic T cells and liver tolerance
Crispe, I. N. (2003) · Nature Reviews Immunology · doi:10.1038/nri981 · Cited by 661
FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity
Nimmerjahn, F., Bruhns, P., Horiuchi, K., & Ravetch, J. V. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.010 · Cited by 660
Are We Ready for Pandemic Influenza?
Webby, R. J., & Webster, R. G. (2003) · Science · doi:10.1126/science.1090350 · Cited by 655
Feltquate, D. M., Heaney, S., Webster, R. G., & Robinson, H. L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2278 · Cited by 555
Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus
YAP, K. L., ADA, G. L., & MCKENZIE, I. F. C. (1978) · Nature · doi:10.1038/273238a0 · Cited by 520
Singh, M., & O'Hagan, D. (1999) · Nature Biotechnology · doi:10.1038/15058 · Cited by 506
Cell-mediated Protection in Influenza Infection
Thomas, P. G., Keating, R., Hulse-Post, D. J., & Doherty, P. C. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1201.051237 · Cited by 466
Self-citationEpitopes Involved in Antibody-Mediated Protection from Ebola Virus
Wilson, J. A., Hevey, M., Bakken, R., Guest, S., Bray, M., Schmaljohn, A. L., & Hart, M. K. (2000) · Science · doi:10.1126/science.287.5458.1664 · Cited by 459
DNA Vaccines: Progress and Challenges
Donnelly, J. J., Wahren, B., & Liu, M. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.633 · Cited by 448
Pushko, P., Parker, M., Ludwig, G. V., Davis, N. L., Johnston, R. E., & Smith, J. F. (1997) · Virology · doi:10.1006/viro.1997.8878 · Cited by 443
Clements, M. L., Betts, R. F., Tierney, E. L., & Murphy, B. R. (1986) · Journal of Clinical Microbiology · doi:10.1128/jcm.24.1.157-160.1986 · Cited by 435
Lukacher, A. E., Braciale, V. L., & Braciale, T. J. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.3.814 · Cited by 434
Eight-plasmid system for rapid generation of influenza virus vaccines
HOFFMANN, E. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00268-2 · Cited by 428
IgG2a restriction of murine antibodies elicited by viral infections.
Coutelier, J. P., van der Logt, J. T., Heessen, F. W., Warnier, G., & Van Snick, J. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.1.64 · Cited by 428
Belshe, R. B., Gruber, W. C., Mendelman, P. M., Mehta, H. B., Mahmood, K., Reisinger, K., Treanor, J., Zangwill, K., Hayden, F. G., Bernstein, D. I., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315323 · Cited by 415
Gessner, J. E., Heiken, H., Tamm, A., & Schmidt, R. E. (1998) · Annals of Hematology · doi:10.1007/s002770050396 · Cited by 404
Lu, X., Tumpey, T. M., Morken, T., Zaki, S. R., Cox, N. J., & Katz, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5903-5911.1999 · Cited by 371
Strategies for designing and optimizing new generation vaccines
Berzofsky, J. A., Ahlers, J. D., & Belyakov, I. M. (2001) · Nature Reviews Immunology · doi:10.1038/35105075 · Cited by 334
Huber, V. C., Lynch, J. M., Bucher, D. J., Le, J., & Metzger, D. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7381 · Cited by 319
Self-citationBinding of monomeric immunoglobulins to Fc receptors of mouse macrophages.
Unkeless, J. C., & Eisen, H. N. (1975) · The Journal of experimental medicine · doi:10.1084/jem.142.6.1520 · Cited by 317
Kopf, M., Abel, B., Gallimore, A., Carroll, M., & Bachmann, M. F. (2002) · Nature Medicine · doi:10.1038/nm0402-373 · Cited by 311
Stephenson, I., Bugarini, R., Nicholson, K. G., Podda, A., Wood, J. M., Zambon, M. C., & Katz, J. M. (2005) · The Journal of Infectious Diseases · doi:10.1086/428948 · Cited by 285
Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase
Kilbourne, E. D., Laver, W. G., Schulman, J. L., & Webster, R. G. (1968) · Journal of Virology · doi:10.1128/jvi.2.4.281-288.1968 · Cited by 273
Role of Dendritic Cell Targeting in Venezuelan Equine Encephalitis Virus Pathogenesis
MacDonald, G. H., & Johnston, R. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.914-922.2000 · Cited by 265
Self-citationThe antiviral activity of antibodies in vitro and in vivo
Parren, P. W. H. I., & Burton, D. R. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)77018-6 · Cited by 261
Kipps, T. J., Parham, P., Punt, J., & Herzenberg, L. A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.1.1 · Cited by 248
Yen, H.-L., Herlocher, L. M., Hoffmann, E., Matrosovich, M. N., Monto, A. S., Webster, R. G., & Govorkova, E. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4075-4084.2005 · Cited by 248
CD1d-Restricted NKT Cells: An Interstrain Comparison
Hammond, K. J. L., Pellicci, D. G., Poulton, L. D., Naidenko, O. V., Scalzo, A. A., Baxter, A. G., & Godfrey, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1164 · Cited by 237
Role of the B‐cell response in recovery of mice from primary influenza virus infection
Gerhard, W., Mozdzanowska, K., Furchner, M., Washko, G., & Maiese, K. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb01009.x · Cited by 237
Alloreactive murine CD8+ T cell clones secrete the Th1 pattern of cytokines.
Fong, T. A., & Mosmann, T. R. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.5.1744 · Cited by 234
Activation of mouse complement by monoclonal mouse antibodies
Neuberger, M. S., & Rajewsky, K. (1981) · European Journal of Immunology · doi:10.1002/eji.1830111212 · Cited by 231
Morris, A. G., Lin, Y.-L., & Askonas, B. A. (1982) · Nature · doi:10.1038/295150a0 · Cited by 199
Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly
De Donato, S., Granoff, D., Minutello, M., Lecchi, G., Faccini, M., Agnello, M., Senatore, F., Verweij, P., Fritzell, B., & Podda, A. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00138-3 · Cited by 184
Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus
Tumpey, T. M., García-Sastre, A., Taubenberger, J. K., Palese, P., Swayne, D. E., & Basler, C. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308391100 · Cited by 175
Minutello, M., Senatore, F., Cecchinelli, G., Bianchi, M., Andreani, T., Podda, A., & Crovari, P. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00185-6 · Cited by 173
Stephenson, I., Nicholson, K. G., Colegate, A., Podda, A., Wood, J., Ypma, E., & Zambon, M. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00632-1 · Cited by 166
Virally induced modulation of murine IgG antibody subclasses.
Coutelier, J. P., van der Logt, J. T., Heessen, F. W., Vink, A., & van Snick, J. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.6.2373 · Cited by 160
Passive and Active Mechanisms Trap Activated CD8+ T Cells in the Liver
John, B., & Crispe, I. N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5222 · Cited by 154
Moran, T. M., Park, H., Fernández-Sesma, A., & Schulman, J. L. (1999) · The Journal of Infectious Diseases · doi:10.1086/314952 · Cited by 149
Deckhut, A. M., Allan, W., McMickle, A., Eichelberger, M. C., Blackman, M. A., Doherty, P. C., & Woodland, D. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2658 · Cited by 145
Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin
Kodihalli, S., Haynes, J. R., Robinson, H. L., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3391-3396.1997 · Cited by 128
Hovden, A., Cox, R. J., & Haaheim, L. R. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2005.01633.x · Cited by 114
Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen.
Klein, J. R., Raulet, D. H., Pasternack, M. S., & Bevan, M. J. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.155.4.1198 · Cited by 113
Intranasal Interleukin‐12 is a Powerful Adjuvant for Protective Mucosal Immunity
Arulanandam, B. P., O’Toole, M., & Metzger, D. W. (1999) · The Journal of Infectious Diseases · doi:10.1086/314996 · Cited by 91
Hocart, M. J., Mackenzie, J. S., & Stewart, G. A. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-9-2439 · Cited by 82
Feng, J. Q., Mozdzanowska, K., & Gerhard, W. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1369-1378.2002 · Cited by 80
Quantitative relationships between an influenza virus and neutralizing antibody
Taylor, H. P., Armstrong, S. J., & Dimmock, N. J. (1987) · Virology · doi:10.1016/0042-6822(87)90466-1 · Cited by 76
Developing vaccines against pandemic influenza
Wood, J. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2001.0981 · Cited by 75
MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice
Higgins, D. A., Carlson, J. R., & Nest, G. V. (1996) · Vaccine · doi:10.1016/0264-410x(95)00240-2 · Cited by 74
Barackman, J. D., Ott, G. S., & O’Hagan, D. T. (1999) · Infection and Immunity · doi:10.1128/iai.67.8.4276-4279.1999 · Cited by 67
Rapid-response vaccines—does DNA offer a solution?
Forde, G. M. (2005) · Nature Biotechnology · doi:10.1038/nbt0905-1059 · Cited by 67
Kedzierska, K., Gruta, N. L. L., Davenport, M. P., Turner, S. J., & Doherty, P. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504851102 · Cited by 67
Schlesinger, J. J., & Chapman, S. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-1-217 · Cited by 65
Preventing and treating influenza
Stöhr, K. (2003) · BMJ · doi:10.1136/bmj.326.7401.1223 · Cited by 55
Zhu, W., Thomas, C. E., Chen, C.-J., Dam, C. N. V., Johnston, R. E., Davis, N., & Sparling, P. F. (2005) · Infection and Immunity · doi:10.1128/iai.73.11.7558-7568.2005 · Cited by 52
Insufficient APC Capacities of Dendritic Cells in Gene Gun-Mediated DNA Vaccination
Lauterbach, H., Gruber, A., Ried, C., Cheminay, C., & Brocker, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4600 · Cited by 46
Zhu, W., Thomas, C. E., & Sparling, P. F. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.08.036 · Cited by 40
Benne, C. A., Harmsen, M., van der Graaff, W. L., Verheul, A. F. M., Snippe, H., & Kraaijeveld, C. A. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00287-3 · Cited by 29
Multi-Envelope HIV Vaccine Safety and Immunogenicity in Small Animals and Chimpanzees
Lockey, T. D., Slobod, K. S., Caver, T. E., D'Costa, S. S., Owens, R. J., McClure, H. M., Compans, R. W., & Hurwitz, J. L. (2000) · Immunologic Research · doi:10.1385/ir:21:1:7 · Cited by 26
Cited by
Expanding roles for CD4+ T cells in immunity to viruses
Swain, S. L., McKinstry, K. K., & Strutt, T. M. (2012) · Nature Reviews Immunology · doi:10.1038/nri3152 · Cited by 956
Vaccines: Correlates of Vaccine‐Induced Immunity
Plotkin, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589862 · Cited by 829
Biological sex affects vaccine efficacy and protection against influenza in mice
Fink, A. L., Engle, K., Ursin, R. L., Tang, W.-Y., & Klein, S. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805268115 · Cited by 253
Cui, X., Vervaeke, P., Gao, Y., Opsomer, L., Sun, Q., Snoeck, J., Devriendt, B., Zhong, Z., & Sanders, N. N. (2024) · npj Vaccines · doi:10.1038/s41541-024-00932-x · Cited by 33
Metadata
- Authors
- Huber, V. C., McKeon, R. M., Brackin, M. N., Miller, L. A., Keating, R., Brown, S. A., Makarova, N., Perez, D. R., MacDonald, G. H., & McCullers, J. A.
- Venue
- Clinical and Vaccine Immunology
- Publisher
- American Society for Microbiology
- Published
- 2006-09
- Volume
- 13
- Issue
- 9
- Pages
- 981-990
- ISSN
- 1556-679X (ISSN-L)
- 1556-6811
- OpenAlex
- W2140205268
- Cited by
- 311
- References
- 68
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.